This is a Validated Antibody Database (VAD) review about cow ESR1, based on 23 published articles (read how Labome selects the articles), using ESR1 antibody in all methods. It is aimed to help Labome visitors find the most suited ESR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ESR1 synonym: estrogen receptor; ER-alpha; estradiol receptor; estrogen receptor alpha; nuclear receptor subfamily 3 group A member 1

Knockout validation
Invitrogen
mouse monoclonal (AER314)
  • western blot knockout validation; human; fig 4
In order to identify and study the expression of a variant estrogen receptor lacking exon 4 in ovarian carcinoma cells, Invitrogen ESR1 antibody (Neomarkers, AER314) was used in western blot knockout validation on human samples (fig 4). Clin Cancer Res (1996) ncbi
Invitrogen
mouse monoclonal (33)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 6a
In order to ask if topical dehydroepiandrosterone ameliorates Meibomian gland dysfunction caused by isotretinoin, Invitrogen ESR1 antibody (Thermo Fisher Scientific, MA1-310) was used in immunohistochemistry - paraffin section on rat samples (fig 6a). Ann Anat (2017) ncbi
mouse monoclonal (TE111.5D11)
  • western blot; human; loading ...; fig s5c
In order to investigate the contribution of cancer-associated long non-coding RNAs in estrogen receptor signaling, Invitrogen ESR1 antibody (Thermo Fisher Scientific, TE111.5D11) was used in western blot on human samples (fig s5c). Sci Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; rabbit; 1:200; loading ...; fig 5a
In order to show that rabbits fed a high-cholesterol diet have higher levels of brain 27-hydroxycholesterol, increased levels of neurodegeneration in the hippocampus, changes in hippocampal estrogen receptor expression, and a decrease in hippocampal mitochond, Invitrogen ESR1 antibody (ThermoScientific, PA5-16476) was used in immunohistochemistry - frozen section on rabbit samples at 1:200 (fig 5a). J Alzheimers Dis (2017) ncbi
mouse monoclonal (TE111.5D11)
  • western blot; mouse; loading ...; fig 1d
  • immunohistochemistry - frozen section; human; loading ...; fig 1a
In order to explore the role of estrogen-induced deregulated myelopoiesis in cancer, Invitrogen ESR1 antibody (ThermoFisher Scientific, TE111.5D11) was used in western blot on mouse samples (fig 1d) and in immunohistochemistry - frozen section on human samples (fig 1a). Cancer Discov (2017) ncbi
mouse monoclonal (TE111.5D11)
  • flow cytometry; human; loading ...; fig 1a
In order to assess the role of host membrane trafficking to latent Epstein-Barr virus infection of B cells, Invitrogen ESR1 antibody (Thermo Scientific, TE111.5D11) was used in flow cytometry on human samples (fig 1a). J Gen Virol (2016) ncbi
mouse monoclonal (33)
  • immunocytochemistry; mouse; 1:50; fig 5
In order to characterize protection of astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression by tibolone, Invitrogen ESR1 antibody (Thermo Scientific, MA1-310) was used in immunocytochemistry on mouse samples at 1:50 (fig 5). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (33)
  • flow cytometry; human; 1:20
In order to characterize enhancement of transcriptome variability and metastatic fitness by highly variable cancer subpopulations, Invitrogen ESR1 antibody (Thermo, MA1310) was used in flow cytometry on human samples at 1:20. Nat Commun (2016) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1a
In order to report the global transcription rates and chromatin changes that accompany the transformation process induced by MLL-ENL, Invitrogen ESR1 antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1a). Cell Rep (2016) ncbi
mouse monoclonal (TE111.5D11)
  • ChIP-Seq; human; fig 5a
In order to characterize SUM-44 breast cancer cells, Invitrogen ESR1 antibody (Thermo Scientific, MA5-13065) was used in ChIP-Seq on human samples (fig 5a). Mol Oncol (2016) ncbi
mouse monoclonal (33)
  • western blot; pig; fig 3
In order to characterize a feedforward mechanism at the G protein-coupled estrogen receptor 1 that controls estrogen enhaced linkage in the vascular endothelial calmodulin network, Invitrogen ESR1 antibody (Pierce, MA1-310) was used in western blot on pig samples (fig 3). J Biol Chem (2016) ncbi
mouse monoclonal (TE111.5D11)
  • immunohistochemistry - paraffin section; chicken; 4 ug/ml; fig 3
In order to examine the expression of progesterone receptor isoforms and estrogen receptor alpha in chickens, Invitrogen ESR1 antibody (NeoMarkers, TE111.5D11) was used in immunohistochemistry - paraffin section on chicken samples at 4 ug/ml (fig 3). Acta Histochem (2015) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1h
  • western blot; mouse; fig 1d
In order to investigate the nuclear function of CEP290, Invitrogen ESR1 antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1h) and in western blot on mouse samples (fig 1d). J Clin Invest (2015) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1h
  • western blot; mouse; fig 1d
In order to elucidate how Myb contributes to poor prognosis of colorectal cancer, Invitrogen ESR1 antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1h) and in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
mouse monoclonal (33)
  • western blot; human
In order to study the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in triple negative breast cancers, Invitrogen ESR1 antibody (Thermo Scientific, MA1-310) was used in western blot on human samples . BMC Cancer (2015) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; human
Invitrogen ESR1 antibody (Thermo, MA5?C13062) was used in chromatin immunoprecipitation on human samples . Cell Death Differ (2015) ncbi
mouse monoclonal (33)
  • immunocytochemistry; human; 1:200
  • western blot; mouse; 1:200
In order to analyze children born with congenital genitourinary tract masculinization disorders by array-comparative genomic hybridization, Invitrogen ESR1 antibody (Thermo, MA1-310) was used in immunocytochemistry on human samples at 1:200 and in western blot on mouse samples at 1:200. Nat Med (2014) ncbi
mouse monoclonal (TE111.5D11)
  • immunoprecipitation; human; 1:200
In order to analyze children born with congenital genitourinary tract masculinization disorders by array-comparative genomic hybridization, Invitrogen ESR1 antibody (Thermo, MA5-13065) was used in immunoprecipitation on human samples at 1:200. Nat Med (2014) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; pig
  • western blot; pig; 1:500
In order to study the mechanisms underlying the effects of a maternal low-protein diet on offspring ovarian steroid synthesis and folliculogenesis, Invitrogen ESR1 antibody (Thermo, MA5-13065) was used in chromatin immunoprecipitation on pig samples and in western blot on pig samples at 1:500. J Steroid Biochem Mol Biol (2014) ncbi
mouse monoclonal (AER314)
  • western blot; human; fig s8
In order to report that ERAP treatment suppresses tamoxifen resistance and enhances tamoxifen responsiveness in ERalpha-positive breast cancer cells, Invitrogen ESR1 antibody (Thermo Fisher, AER314) was used in western blot on human samples (fig s8). Nat Commun (2013) ncbi
mouse monoclonal (AER314)
  • western blot knockout validation; human; fig 4
In order to identify and study the expression of a variant estrogen receptor lacking exon 4 in ovarian carcinoma cells, Invitrogen ESR1 antibody (Neomarkers, AER314) was used in western blot knockout validation on human samples (fig 4). Clin Cancer Res (1996) ncbi
Abcam
rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 1
  • western blot; mouse; 1:500; fig 1
Abcam ESR1 antibody (Abcam, ab75635) was used in immunohistochemistry on mouse samples at 1:100 (fig 1) and in western blot on mouse samples at 1:500 (fig 1). Sci Rep (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
Abcam ESR1 antibody (Abcam, ab75635) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Reproduction (2015) ncbi
Sigma-Aldrich
rabbit polyclonal
  • immunohistochemistry - paraffin section; cow; fig 2b
Sigma-Aldrich ESR1 antibody (Sigma-Aldrich, SAB2100712) was used in immunohistochemistry - paraffin section on cow samples (fig 2b). Reproduction (2016) ncbi
EMD Millipore
rabbit monoclonal (60C)
  • western blot; human; loading ...; fig 2a; 2g
EMD Millipore ESR1 antibody (Millipore, 04-820) was used in western blot on human samples (fig 2a; 2g). Oncotarget (2016) ncbi
Articles Reviewed
  1. Ibrahim M, Elwan W. Role of topical dehydroepiandrosterone in ameliorating isotretinoin-induced Meibomian gland dysfunction in adult male albino rat. Ann Anat. 2017;211:78-87 pubmed publisher
  2. Aiello A, Bacci L, Re A, Ripoli C, Pierconti F, Pinto F, et al. MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells. Sci Rep. 2016;6:38414 pubmed publisher
  3. Brooks S, Dykes A, Schreurs B. A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus. J Alzheimers Dis. 2017;56:185-196 pubmed publisher
  4. Svoronos N, Perales Puchalt A, Allegrezza M, Rutkowski M, Payne K, Tesone A, et al. Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells. Cancer Discov. 2017;7:72-85 pubmed publisher
  5. Nanbo A, Kachi K, Yoshiyama H, Ohba Y. Epstein-Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapse. J Gen Virol. 2016;97:2989-3006 pubmed publisher
  6. Ladd B, Mazzola A, Bihani T, Lai Z, BRADFORD J, Collins M, et al. Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations. Oncotarget. 2016;7:54120-54136 pubmed publisher
  7. Ávila Rodriguez M, Garcia Segura L, Hidalgo Lanussa O, Baez E, Gonzalez J, Barreto G. Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression. Mol Cell Endocrinol. 2016;433:35-46 pubmed publisher
  8. Nguyen A, Yoshida M, Goodarzi H, Tavazoie S. Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness. Nat Commun. 2016;7:11246 pubmed publisher
  9. Garcia Cuellar M, Büttner C, Bartenhagen C, Dugas M, Slany R. Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes. Cell Rep. 2016;15:310-22 pubmed publisher
  10. Irish J, Mills J, Turner Ivey B, Wilson R, Guest S, Rutkovsky A, et al. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ER? in SUM-44 breast cancer cells and is associated with ER? over-expression in breast cancer. Mol Oncol. 2016;10:850-65 pubmed publisher
  11. Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, et al. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. J Biol Chem. 2016;291:10805-23 pubmed publisher
  12. Kobayashi Y, Yamamoto Y, Kageyama S, Hirayama H, Kimura K, Okuda K. Regulation of bovine oviductal NO synthesis by follicular steroids and prostaglandins. Reproduction. 2016;151:577-87 pubmed publisher
  13. Ma Y, Guo H, Zhang L, Tao L, Yin A, Liu Z, et al. Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β. Sci Rep. 2016;6:21467 pubmed publisher
  14. González Morán M. Immunohistochemical localization of progesterone receptor isoforms and estrogen receptor alpha in the chicken oviduct magnum during development. Acta Histochem. 2015;117:681-7 pubmed publisher
  15. Xiong W, Zhang L, Yu L, Xie W, Man Y, Xiong Y, et al. Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis. Reproduction. 2015;150:507-16 pubmed publisher
  16. Slaats G, Saldivar J, Bacal J, Zeman M, Kile A, Hynes A, et al. DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome. J Clin Invest. 2015;125:3657-66 pubmed publisher
  17. Malaterre J, Pereira L, Putoczki T, Millen R, Paquet Fifield S, Germann M, et al. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice. Oncogene. 2016;35:2475-84 pubmed publisher
  18. Zhao H, Agazie Y. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment. BMC Cancer. 2015;15:109 pubmed publisher
  19. Yang Z, Broz D, Noderer W, Ferreira J, Overton K, Spencer S, et al. p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress. Cell Death Differ. 2015;22:560-73 pubmed publisher
  20. Tannour Louet M, Han S, Louet J, Zhang B, Romero K, Addai J, et al. Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action. Nat Med. 2014;20:715-24 pubmed publisher
  21. Sui S, He B, Jia Y, Li R, Cai D, Li X, et al. Maternal protein restriction during gestation and lactation programs offspring ovarian steroidogenesis and folliculogenesis in the prepubertal gilts. J Steroid Biochem Mol Biol. 2014;143:267-76 pubmed publisher
  22. Yoshimaru T, Komatsu M, Matsuo T, Chen Y, Murakami Y, Mizuguchi K, et al. Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun. 2013;4:2443 pubmed publisher
  23. Park W, Choi J, Hwang E, Lee J. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas. Clin Cancer Res. 1996;2:2029-35 pubmed